Literature DB >> 35397700

A primary rectal neoplasm with novel DDX5-TFEB fusion.

Mengxin Zhang1, Xiaoxue Yin1, Junru Chen2, Sha Zhu2, Linmao Zheng1, Hao Zeng2, Qiao Zhou1, Ni Chen3.   

Abstract

We report a case of primary rectal neoplasm with a novel DDX5-TFEB fusion in a 14-year-old boy. Histologically, the neoplasm was composed of epithelioid tumor cells with abundant clear to eosinophilic cytoplasm, arranged in nests with rich stromal capillary vasculature. Immunohistochemically, the tumor cells were positive for transcription factor EB (TFEB) and negative for PAX8, TFE3, HMB45, and PCK. TFEB gene rearrangement and low-level amplification were identified using break-apart fluorescence in situ hybridization. Next-generation sequencing identified a heretofore unreported DDX5-TFEB gene fusion, which was confirmed by using reverse transcription-polymerase chain reaction and Sanger sequencing. The major morphological differential diagnoses include perivascular epithelioid cell tumor, microphthalmia-associated transcriptional factor family translocation renal cell carcinoma, and alveolar soft part sarcoma. The morphological, immumophenotypical, and genetic characteristics of this tumor did not fit well with current classification, but it may represent an unusual PEComa-like tumor with a novel DDX5-TFEB fusion.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  DDX5; Gene fusion; Rectal neoplasm; TFEB

Mesh:

Substances:

Year:  2022        PMID: 35397700     DOI: 10.1007/s00428-022-03316-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.535


  12 in total

1.  Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs): Expanding the Genomic Spectrum.

Authors:  Qiu-Yuan Xia; Xiao-Tong Wang; Ru Fang; Zhe Wang; Ming Zhao; Hong Chen; Ni Chen; Xiao-Dong Teng; Xuan Wang; Xue Wei; Sheng-Bing Ye; Rui Li; Heng-Hui Ma; Zhen-Feng Lu; Xiao-Jun Zhou; Qiu Rao
Journal:  Am J Surg Pathol       Date:  2020-04       Impact factor: 6.394

2.  Clear Cell Tumor With Melanocytic Differentiation and ACTIN-MITF Translocation: Report of 7 Cases of a Novel Entity.

Authors:  Arnaud de la Fouchardiere; Daniel Pissaloux; Franck Tirode; Marie Karanian; Christopher D M Fletcher; John Hanna
Journal:  Am J Surg Pathol       Date:  2021-07-01       Impact factor: 6.394

3.  The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.

Authors:  M Ladanyi; M Y Lui; C R Antonescu; A Krause-Boehm; A Meindl; P Argani; J H Healey; T Ueda; H Yoshikawa; A Meloni-Ehrig; P H Sorensen; F Mertens; N Mandahl; H van den Berghe; R Sciot; P Dal Cin; J Bridge
Journal:  Oncogene       Date:  2001-01-04       Impact factor: 9.867

4.  Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.

Authors:  Steffen Durinck; Eric W Stawiski; Andrea Pavía-Jiménez; Zora Modrusan; Payal Kapur; Bijay S Jaiswal; Na Zhang; Vanina Toffessi-Tcheuyap; Thong T Nguyen; Kanika Bajaj Pahuja; Ying-Jiun Chen; Sadia Saleem; Subhra Chaudhuri; Sherry Heldens; Marlena Jackson; Samuel Peña-Llopis; Joseph Guillory; Karen Toy; Connie Ha; Corissa J Harris; Eboni Holloman; Haley M Hill; Jeremy Stinson; Celina Sanchez Rivers; Vasantharajan Janakiraman; Weiru Wang; Lisa N Kinch; Nick V Grishin; Peter M Haverty; Bernard Chow; Julian S Gehring; Jens Reeder; Gregoire Pau; Thomas D Wu; Vitaly Margulis; Yair Lotan; Arthur Sagalowsky; Ivan Pedrosa; Frederic J de Sauvage; James Brugarolas; Somasekar Seshagiri
Journal:  Nat Genet       Date:  2014-11-17       Impact factor: 38.330

Review 5.  Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.

Authors:  Eric C Kauffman; Christopher J Ricketts; Soroush Rais-Bahrami; Youfeng Yang; Maria J Merino; Donald P Bottaro; Ramaprasad Srinivasan; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2014-07-22       Impact factor: 14.432

6.  Multi-talented DEAD-box proteins and potential tumor promoters: p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase (DDX17).

Authors:  Ralf Janknecht
Journal:  Am J Transl Res       Date:  2010-05-05       Impact factor: 4.060

7.  Clear cell tumor with melanocytic differentiation and MITF-CREM translocation: a novel entity similar to clear cell sarcoma.

Authors:  Arnaud de la Fouchardiere; Daniel Pissaloux; Franck Tirode; John Hanna
Journal:  Virchows Arch       Date:  2021-01-18       Impact factor: 4.064

8.  TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1.

Authors:  Anna Caliò; Shuko Harada; Matteo Brunelli; Serena Pedron; Diego Segala; Sofia Canete Portillo; Cristina Magi-Galluzzi; George J Netto; Alexander C Mackinnon; Guido Martignoni
Journal:  Mod Pathol       Date:  2020-11-18       Impact factor: 7.842

9.  Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2) and the first report of a female case.

Authors:  J M Shipley; S Birdsall; J Clark; J Crew; S Gill; M Linehan; J Gnarra; S Fisher; I W Craig; C S Cooper
Journal:  Cytogenet Cell Genet       Date:  1995

10.  Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.

Authors:  Cristina R Antonescu; Francois Le Loarer; Juan-Miguel Mosquera; Andrea Sboner; Lei Zhang; Chun-Liang Chen; Hsiao-Wei Chen; Nursat Pathan; Thomas Krausz; Brendan C Dickson; Ilan Weinreb; Mark A Rubin; Meera Hameed; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2013-06-05       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.